A schistosomiasis research agenda - PubMed (original) (raw)

A schistosomiasis research agenda

Daniel G Colley et al. PLoS Negl Trop Dis. 2007.

Abstract

There is a long and rich history of research and control in the field of schistosomiasis that has resulted in major scientific and public health accomplishments. Examples of such findings and accomplishments include immunologic regulation in chronic infections, the association of helminth infections with Th1-regulating Th2-type immune responses, the critical role of interleukin-13 in fibrogenesis, and the development and validation of the "dose pole" for determining praziquantel dosages in the field. Perhaps in part because of this broad and successful history, those who work on schistosomiasis come from a wide variety of backgrounds and interests. While such variety is enriching to the field, it sometimes results in diverse opinions about which of the many research opportunities should be pursued. Such diversity, we believe, has at times led to a divisiveness that has harmed overall progress in the field. Partly in response to such events, we have worked with as many of those interested in schistosomiasis as we could identify to develop what we feel is a comprehensive and cohesive agenda for schistosomiasis research.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

None

1659 adult Schistosoma mansoni worms obtained by live surgical perfusion of an 18 year-old patient in 1970

None

Cross-section of a Schistosoma mansoni adult worm pair in the mesenteric venule of a mouse; H&E stain

Comment in

References

    1. Domingo EO, Warren KS. Endogenous desensitization: Changing host granulomatous response to schistosome eggs at different stages of infection with Schistosoma mansoni. . Am J Pathol. 1968;52:369–379. - PMC - PubMed
    1. Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. . J Exp Med. 1991;173:159–166. - PMC - PubMed
    1. Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology. 2001;34:273–282. - PubMed
    1. Hall A, Nokes C, Wen S-T, Adjei S, Kihamia C, et al. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Trans R Soc Trop Med Hyg. 1999;93:653–658. - PubMed
    1. Montresor A, Engels D, Chitsulo L, Bundy DAP, Brooker S, et al. Development and validation of a ‘tablet pole’ for the administration of praziquantel in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2001;95:542–544. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources